Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

for
Amyloidosis, Hereditary, Amyloidosis Cardiac,
Location: Dallas TX, Cleveland OH, New York NY
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 30 - 70+

Code: NCT05489549

Recruiting
Active & Responsive

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

for
Nontuberculous Mycobacterium Infection
Location: Dallas TX, Birmingham AL, Denver CO, Minneapolis MN,
Sponsor: Chris Goss

Sex: All

Age: 18+

Code: NCT04294043

Phase1, Recruiting
Active & Responsive

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

for
Gastric Adenocarcinoma,
Location: Dallas TX, Westwood KS, Chicago IL, Milwaukee WI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05365581

Phase1, Recruiting
Active & Responsive

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

for
Hereditary Hemorrhagic Telangiectasia,
Location: Dallas TX, St Louis MO, Birmingham AL, Aurora CO,
Sponsor: Cure HHT

Sex: All

Age: 0+

Code: NCT06259292

Recruiting
Active & Responsive

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

for
Mesial Temporal Lobe Epilepsy
Location: Dallas TX, Houston TX, Little Rock AR, New Orleans LA,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05135091

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma

for
Advanced Unresectable Hepatocellular Carcinoma
Location: Dallas TX, Fort Worth TX, Nashville TN, Baltimore MD
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT07175441

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia

for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Atlanta GA, Philadelphia PA, New York NY,
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 1 - 17

Code: NCT07517133

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

for
Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Atlanta GA, Philadelphia PA, New York NY
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 1 - 17

Code: NCT07506863

Phase3, Recruiting
Active & Responsive

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF

for
Cystic Fibrosis (CF), New Diagnostics
Location: Dallas TX, St Louis MO, Milwaukee WI, Minneapolis MN,
Sponsor: Chris Goss

Sex: All

Age: 16+

Code: NCT07312734

Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: Dallas TX, Lawrence KS, Atlanta GA, Chicago IL,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

for
Spasticity
Location: Dallas TX, Overland Park KS, Downey CA, Elkins Park PA
Sponsor: Ipsen

Sex: All

Age: 18 - 70

Code: NCT04752774

Phase1, Phase2, Recruiting
Active & Responsive

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

for
Non Small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Philadelphia PA
Sponsor: Integro Theranostics

Sex: All

Age: 18+

Code: NCT07276789

Phase2, Recruiting
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Dallas TX, Houston TX, Nashville TN, Chicago IL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT06971731

Phase3, Recruiting
Active & Responsive

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Dallas TX, Birmingham AL, Indianapolis IN,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase1, Recruiting
Active & Responsive

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Dallas TX, Omaha NE, Gainesville FL, Fayetteville NC,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT07570862

Phase2, Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: Dallas TX, Aurora CO, Atlanta GA, Minneapolis MN,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Dallas TX, Oklahoma City OK, Jackson MS, Nashville TN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Dallas TX, Houston TX, San Antonio TX, Kansas City KS,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Dallas TX, Temple TX, Austin TX, Houston TX, Wichita KS,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

Customized TULSA-PRO Ablation Registry

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: Dallas TX, San Antonio TX, Jacksonville FL, York PA,
Sponsor: Profound Medical Inc.

Sex: Male

Age: 18+

Code: NCT05001477

Recruiting